353 related articles for article (PubMed ID: 21182981)
1. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
Zhang E; Zhang C; Su Y; Cheng T; Shi C
Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrially targeted anti-cancer agents.
Biasutto L; Dong LF; Zoratti M; Neuzil J
Mitochondrion; 2010 Nov; 10(6):670-81. PubMed ID: 20601192
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria as therapeutic targets for the treatment of malignant disease.
Fulda S; Kroemer G
Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
[TBL] [Abstract][Full Text] [Related]
4. Drug development in oncology assisted by noninvasive optical imaging.
Sancey L; Dufort S; Josserand V; Keramidas M; Righini C; Rome C; Faure AC; Foillard S; Roux S; Boturyn D; Tillement O; Koenig A; Boutet J; Rizo P; Dumy P; Coll JL
Int J Pharm; 2009 Sep; 379(2):309-16. PubMed ID: 19467306
[TBL] [Abstract][Full Text] [Related]
5. Mitochondriotoxic compounds for cancer therapy.
Fantin VR; Leder P
Oncogene; 2006 Aug; 25(34):4787-97. PubMed ID: 16892091
[TBL] [Abstract][Full Text] [Related]
6. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
7. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
8. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
9. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Moreno-Sánchez R
Mol Aspects Med; 2010 Feb; 31(1):29-59. PubMed ID: 20026172
[TBL] [Abstract][Full Text] [Related]
10. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.
Sivapackiam J; Gammon ST; Harpstrite SE; Sharma V
Methods Mol Biol; 2010; 596():141-81. PubMed ID: 19949924
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
[TBL] [Abstract][Full Text] [Related]
13. Targeted drug delivery to mammalian mitochondria in living cells.
Weissig V
Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria as targets for established and novel anti-cancer agents.
Grad JM; Cepero E; Boise LH
Drug Resist Updat; 2001 Apr; 4(2):85-91. PubMed ID: 11512525
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Gindy ME; Prud'homme RK
Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
[TBL] [Abstract][Full Text] [Related]
16. Active targeting schemes for nanoparticle systems in cancer therapeutics.
Byrne JD; Betancourt T; Brannon-Peppas L
Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondria for cancer therapy.
Hockenbery DM
Environ Mol Mutagen; 2010 Jun; 51(5):476-89. PubMed ID: 20213841
[TBL] [Abstract][Full Text] [Related]
19. Chemical approaches to the discovery and development of cancer therapies.
Neidle S; Thurston DE
Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted drug delivery system for cancer treatment.
Chen ZP; Li M; Zhang LJ; He JY; Wu L; Xiao YY; Duan JA; Cai T; Li WD
J Drug Target; 2016; 24(6):492-502. PubMed ID: 26548930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
